Cargando…

A novel perineal shield for low-dose-rate prostate brachytherapy

PURPOSE: To study the impact on radiation exposure to staff through the use of an original perineal shield during low-dose-rate prostate brachytherapy. MATERIAL AND METHODS: We designed a 1 mm thick stainless steel shield that duplicates and is able to slide directly over a standard commercialized p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weiner, Joseph P., Schwartz, David, Safdieh, Joseph, Polubarov, Alex, Telivala, Tejas, Worth, Matthew, Schreiber, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2015
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4499515/ https://www.ncbi.nlm.nih.gov/pubmed/26207107 http://dx.doi.org/10.5114/jcb.2015.52071

Ejemplares similares

Utilization of prostate brachytherapy for low risk prostate cancer: Is the decline overstated?
por: Safdieh, Joseph, et al.
Publicado: (2016)

Low dose rate prostate brachytherapy
por: Stish, Bradley J., et al.
Publicado: (2018)

Clinical and biochemical outcomes of men undergoing radical prostatectomy or radiation therapy for localized prostate cancer
por: Schreiber, David, et al.
Publicado: (2015)

Perineal recurrence of prostate cancer post-brachytherapy
por: Cooper, Sian, et al.
Publicado: (2019)

Perineal recurrence of prostate cancer six years after trans-perineal brachytherapy
por: Eppinga, Wietse, et al.
Publicado: (2014)

Long-term tolerance and outcomes for dose escalation in early salvage post-prostatectomy radiation therapy
por: Safdieh, Joseph J., et al.
Publicado: (2014)

Salvage high-dose-rate interstitial brachytherapy for perineal recurrence of prostate cancer after surgery and radiotherapy: a case report
por: Vavassori, Andrea, et al.
Publicado: (2020)

Association of Nadir Prostate-specific Antigen >0.5 ng/mL after Dose-escalated External Beam Radiation with Prostate Cancer-specific Endpoints
por: Sheth, Niki, et al.
Publicado: (2018)

Focal low-dose rate brachytherapy for the treatment of prostate cancer
por: Tong, William Y, et al.
Publicado: (2013)

Focal low-dose-rate prostate brachytherapy for low- and intermediate-risk prostate cancer
por: Kunogi, Hiroaki, et al.
Publicado: (2020)

Low-dose-rate or high-dose-rate brachytherapy in treatment of prostate cancer – between options
por: Skowronek, Janusz
Publicado: (2013)

Treatment patterns of high-dose-rate and low-dose-rate brachytherapy as monotherapy for prostate cancer
por: Barnes, Justin, et al.
Publicado: (2019)

The Impact of Tobacco Use on Outcomes and Toxicity in a Predominantly Minority Population of Males with Prostate Cancer Receiving External Beam Radiation
por: Lee, Anna, et al.
Publicado: (2017)

Response to ‘Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer’
por: Slevin, Finbar, et al.
Publicado: (2020)

Racial and socioeconomic disparities in the selection of prostate brachytherapy
por: Schreiber, David, et al.
Publicado: (2013)

Pulmonary Metastases After Low-Dose-Rate Brachytherapy for Localized Prostate Cancer
por: Kido, Masahito, et al.
Publicado: (2014)

Control charts for evaluation of quality of low-dose-rate brachytherapy for prostate cancer
por: Nasser, Nicola J., et al.
Publicado: (2022)

The oncologic and safety outcomes of low-dose-rate brachytherapy for the treatment of prostate cancer
por: Tanaka, Nobumichi
Publicado: (2023)

Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer
por: Yamazaki, Hideya, et al.
Publicado: (2020)

A Phase 2 Randomized Pilot Study Comparing High-Dose-Rate Brachytherapy and Low-Dose-Rate Brachytherapy as Monotherapy in Localized Prostate Cancer
por: Hathout, Lara, et al.
Publicado: (2019)

High dose-rate brachytherapy in the treatment of prostate cancer
por: Mendez, Lucas C., et al.
Publicado: (2018)

Dose Distribution of High Dose-Rate and Low Dose-Rate Prostate Brachytherapy at Different Intervals—Impact of a Hydrogel Spacer and Prostate Volume
por: Haddad, Hathal, et al.
Publicado: (2023)

Hemiablative Focal Low Dose Rate Brachytherapy: A Phase II Trial Protocol
por: Fernandez Ots, Ana, et al.
Publicado: (2016)

High-dose-rate brachytherapy with external beam radiotherapy versus low-dose-rate brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer
por: Yamazaki, Hideya, et al.
Publicado: (2021)

Evaluation of the dosimetric impact of loss and displacement of seeds in prostate low-dose-rate brachytherapy
por: Wang, Yinkun, et al.
Publicado: (2015)

The impact of body mass index on dosimetric quality in low-dose-rate prostate brachytherapy
por: Echevarria, Michelle I., et al.
Publicado: (2016)

Evaluation of the MIM Symphony treatment planning system for low‐dose‐rate‐ prostate brachytherapy
por: Dhanesar, Sandeep K., et al.
Publicado: (2015)

Focal application of low-dose-rate brachytherapy for prostate cancer: a pilot study
por: Mahdavi, S. Sara, et al.
Publicado: (2017)

Clinical Efficacy and Openness to New Challenges of Low Dose Rate Brachytherapy for Prostate Cancer
por: Kato, Manabu, et al.
Publicado: (2023)

Focal partial salvage low-dose-rate brachytherapy for local recurrent prostate cancer after permanent prostate brachytherapy with a review of the literature
por: Kunogi, Hiroaki, et al.
Publicado: (2016)

Testicular shielding in penile brachytherapy
por: Bindal, Arpita, et al.
Publicado: (2015)

Brachytherapy for cervix cancer: low-dose rate or high-dose rate brachytherapy – a meta-analysis of clinical trials
por: Viani, Gustavo A, et al.
Publicado: (2009)

Evaluation of the eclipse electron Monte Carlo dose calculation for small fields
por: Xu, Zhigang, et al.
Publicado: (2009)

Parameters predicting for prostate specific antigen response rates at one year post low-dose-rate intraoperative prostate brachytherapy
por: Martell, Kevin, et al.
Publicado: (2017)

Distinguishing prostate-specific antigen bounces from biochemical failure after low-dose-rate prostate brachytherapy
por: Hackett, Cian, et al.
Publicado: (2014)

A Brief Review of Low-Dose Rate (LDR) and High-Dose Rate (HDR) Brachytherapy Boost for High-Risk Prostate
por: Fischer-Valuck, Benjamin W., et al.
Publicado: (2019)

High-dose-rate brachytherapy delivered in two fractions as monotherapy for low-risk prostate cancer
por: Cendales, Ricardo, et al.
Publicado: (2015)

Small cell carcinoma of the prostate after low-dose-rate brachytherapy: a case report
por: Van Bos, Eva, et al.
Publicado: (2020)

Clinical outcomes of low-dose-rate brachytherapy based radiotherapy for intermediate risk prostate cancer
por: Okamoto, Keisei, et al.
Publicado: (2020)

Ischemic proctitis after low‐dose‐rate brachytherapy using hydrogel spacer for prostate cancer
por: Toriumi, Ren, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_baoqmauab68ntdt9j94qm106kb